变量 | 肺粘液腺癌组(n = 292) | 非粘液腺癌组(n = 686) | c2/t/Z值 | P值 |
空泡或空洞征,n (%) | 74 (25.3) | 94 (13.7) | 19.505 | <0.001b |
存在实体、微乳头成分,n (%) | 81 (27.7) | 193 (28.1) | 0.016 | 0.900b |
侵犯脏层胸膜,n (%) | 34 (11.6) | 74 (10.8) | 0.153 | 0.696b |
解剖部位,n (%) |
|
| 2.354 | 0.125b |
中央型 | 6 (2.1) | 6 (0.9) | ||
周围型 | 286 (97.9) | 680 (99.1) | ||
手术方式,n (%) |
|
| 22.131 | <0.001b |
电视辅助胸腔镜手术 | 280 (95.9) | 586 (85.4) | ||
机器人辅助胸腔镜手术 | 12 (4.1) | 100 (14.6) | ||
PD-1/PD-L1, median (P25, P75) | 0.00 (0.00, 1.00) | 0.00 (0.00, 0.00) | −3.998 | <0.001d |
Ki-67, median (P25, P75) | 5.00 (3.00, 10.00) | 5.00 (5.00, 10.00) | −4.246 | <0.001d |
T分期,n (%) |
|
|
|
|
T1a | 43 (14.7) | 120 (17.5) | 127.46 | <0.001b |
T1b | 117 (40.1) | 308 (44.9) | ||
T1c | 63 (21.6) | 216 (31.4) | ||
T2a | 41 (14.0) | 22 (3.3) | ||
T2b | 7 (2.4) | 9 (1.3) | ||
T3 | 21 (7.2) | 11 (1.6) | ||
N分期,n (%) |
|
|
|
|
N0 | 269 (92.1) | 673 (98.1) | 23.726 | <0.001b |
N1 | 17 (5.8) | 6 (0.9) | ||
N2 | 6 (2.1) | 7 (1.0) | ||
TNM分期,n (%) |
|
|
|
|
IA1 | 41 (14.0) | 120 (17.5) |
| <0.001c |
IA2 | 112 (38.4) | 306 (44.6) | ||
IA3 | 58 (19.9) | 213 (31.0) | ||
IB | 35 (12.0) | 20 (2.9) | ||
IIA | 7 (2.4) | 8 (1.2) | ||
IIB | 31 (10.6) | 11 (1.6) | ||
IIIA | 6 (2.1) | 4 (0.6) | ||
IIIB | 2 (0.7) | 4 (0.6) | ||
淋巴结清扫组数(组),median (P25, P75) | 6.00 (6.00, 7.00) | 6.00 (6.00, 7.00) | −1.152 | 0.249d |
淋巴结清扫数量(个),median (P25, P75) | 15.00 (10.00, 19.00) | 11.00 (8.00, 15.00) | 6.944 | <0.001d |
阳性淋巴结组数(组),median (P25, P75) | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | −2.673 | 0.008d |
阳性淋巴结数量(个),median (P25, P75) | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | −2.623 | 0.009d |